Catalyst Health Ventures Halfway Home on Early Stage Fund
With more and more VC firms going late stage in hopes of netting big returns for LPs, it has been a rarity to see a venture capital firm in 2012 trying to raise capital to support an early stage biotech and life science fund. In fact, it is exceedingly rare to see one succeeding. But, about halfway to a target of around $60 million, what you see is what you get with Catalyst Health Ventures...
8 November 2012•2 mins read
